Rock Springs Capital LLC 4
4 · Homology Medicines, Inc. · Filed Apr 4, 2018
Insider Transaction Report
Form 4Exit
Rock Springs Capital Management LP
10% Owner
Transactions
- Conversion
Common Stock
[F1]2018-04-02+395,845→ 395,845 total(indirect: See footnote) - Purchase
Common Stock
[F1]2018-04-02$16.00/sh+250,000$4,000,000→ 645,845 total(indirect: See footnote) - Conversion
Series B Preferred Stock
[F2][F1]2018-04-02−395,845→ 0 total(indirect: See footnote)→ Common Stock (395,845 underlying)
Footnotes (2)
- [F1]The securities reported herein are held of record by Rock Springs Capital Master Fund LP ("Master Fund"). Rock Springs Capital LLC ("RSC") is the general partner of Rock Springs Capital Management LP ("RSCM") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the securities held directly by Master Fund.
- [F2]Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock.